Records containing: Substance-Related Disorders
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-09-29Cognitive Therapy for PTSD in Addiction Treatment
-
CLINICAL_TRIALS study record update · 2011-07-20Women's Prison TC: Outcomes, Process & Economic Analysis
-
CLINICAL_TRIALS study record update · 2010-12-06Impaired Decision-making in Adolescents: A Vulnerability Factor for the Development of Substance Use and Abuse.
-
CLINICAL_TRIALS study record update · 2010-10-13Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone in Human Subjects
-
CLINICAL_TRIALS study record update · 2009-08-12Computer-delivered Psychosocial Intervention for Adolescent Substance Use Disorders
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-06-18Cognitive Remediation in the Initial Phase of Substance Abuse Treatment: Feasibility and Efficacy
-
CLINICAL_TRIALS study record update · 2009-06-15Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)
-
CLINICAL_TRIALS study record update · 2009-03-06Integrated CBT for Substance Use and Depressive Disorders
-
CLINICAL_TRIALS study record update · 2008-08-01Modulation of Opiate Reward by NK1 Antagonism: A Laboratory-Based Proof of Concept Study
-
CLINICAL_TRIALS study record update · 2008-06-10Brief Intervention in Substance Use Among Adolescent Psychiatric Patients: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2007-11-05A Double-Blind Placebo- and Active-Controlled, Single-Dose Crossover PD and PK Study to Evaluate the Safety, Tolerability and Abuse Liability of IV Administered NRP104 25 mg and 50 mg in Adult Volunteers With Histories of Stimulant Abuse
-
CLINICAL_TRIALS study record update · 2007-11-05A Double-Blind, Randomized, Placebo and Active-Controlled, Six-Period Crossover Study to Evaluate the Likeability, Safety, and Abuse Liability of NRP104 in Healthy Adult Volunteers With Histories of Stimulant Abuse